Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Microplates is a life science tools company that designs and manufactures high-performance microplates used in discovery sciences, biochemical analysis, and research workflows. Its products are built primarily from cyclo-olefin polymer materials and are optimized for imaging, fluorescence, luminescence, microscopy, and high-throughput screening applications. The company emphasizes ultra-flat, low-autofluorescence, chemically resistant plates produced in cleanroom manufacturing environments, including ISO 13485-registered facilities. Aurora Microplates was acquired by Zeon Corporation in 2022 and continues to operate as an active operating business within Zeon’s healthcare and life sciences strategy. Rather than developing therapeutics, the company supplies enabling laboratory hardware used in early-stage drug discovery and diagnostics-related research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora Microplates.